Can Neuroimaging Markers of Vascular Pathology Explain Cognitive Performance in Adults With Sickle Cell Anemia? A review of the Literature.
Adults with homozygous sickle cell anemia have, on average, lower cognitive function than unaffected controls. The mechanisms underlying cognitive deterioration in this population are poorly understood, but cerebral small vessel disease (CSVD) is likely to be implicated. We conducted a systematic review using the Prisma Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines of articles that included both measures of cognitive function and magnetic resonance imaging (MRI) neuroimaging markers of small vessel disease. While all five studies we identified reported small vessel disease by MRI, only two of them found a significant relationship between structural changes and cognitive performance. Differences in methodologies and small sample sizes likely accounted for the discrepancies between the studies. We conclude that while MRI is a valuable tool to identify markers of CSVD in this population, larger studies are needed to definitely establish a link between MRI-detectable abnormalities and cognitive function in sickle cell anemia.
a Department of Epidemiology , University of Pittsburgh School of Public Health , Pittsburgh , PA , USA.
Dana R
DR
Jorgensen
a Department of Epidemiology , University of Pittsburgh School of Public Health , Pittsburgh , PA , USA.
Caterina
C
Rosano
b Adult Sickle Cell Program, Division of Hematology/Oncology , University of Pittsburgh , Pittsburgh , PA , USA.
Enrico M
EM
Novelli
D000328:Adult; D000755:Anemia, Sickle Cell / Q000150:complications*; D059345:Cerebral Small Vessel Diseases / Q000000981:diagnostic imaging / Q000473:pathology*; D003072:Cognition Disorders / Q000209:etiology*; D006801:Humans; D008279:Magnetic Resonance Imaging; D059906:Neuroimaging / Q000379:methods*
Cerebral small vessel disease (CSVD); cerebrovascular; cognition; neuroimaging; sickle cell anemia
Lancet Neurol. 2010 Jul;9(7):689-701
20610345
Neuroimage. 2010 Dec;53(4):1244-55
20600995
Psychiatry Res. 2015 Jul 30;233(1):18-22
26002434
Blood Cells Mol Dis. 2015 Jan;54(1):17-25
25294561
JAMA. 2010 May 12;303(18):1823-31
20460621
Neurology. 1993 Feb;43(2):250-60
8094895
Dement Geriatr Cogn Dis Extra. 2012 Jan;2:169-79
22590477
Lancet Neurol. 2010 Sep;9(9):895-905
20723846
Brain. 2005 Sep;128(Pt 9):2034-41
15947059
Psychiatry Res. 1993 Jun;50(2):121-39
8378488
Indian J Med Res. 2011 Oct;134:532-7
22089617
Br J Haematol. 2010 Dec;151(5):425-9
20955412
Blood. 1998 Jan 1;91(1):288-94
9414296
Arch Neurol. 1993 Jun;50(6):629-35
8503800
Neuroradiology. 1994;36(2):101-3
8183443
Neurology. 2014 Mar 11;82(10):835-41
24523480
Lancet Neurol. 2013 May;12(5):483-97
23602162
Hematol Rep. 2013 Feb 05;5(1):8-12
23888239
Curr Hypertens Rep. 2003 Jun;5(3):255-61
12724059
Diabetes Care. 2010 Jan;33(1):168-70
19808915
Diabetes. 2006 Apr;55(4):1106-13
16567535
Stroke. 2011 Sep;42(9):2672-713
21778438
Lancet Neurol. 2003 Feb;2(2):89-98
12849265
J Pediatr. 1992 Mar;120(3):360-6
1538280
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
19622511
Stroke. 1978 Jan-Feb;9(1):45-52
622745
Pediatr Radiol. 2007 Sep;37(9):863-9
17619872
Blood. 1984 Jul;64(1):282-7
6733278
Pediatr Blood Cancer. 2010 Mar;54(3):461-4
19813251
Diabetes Care. 2005 Jun;28(6):1431-7
15920064
Stroke. 2010 Oct;41(10 Suppl):S154-8
20876494
Cerebrovasc Dis. 2015;39(3-4):181-9
25765995
AJNR Am J Neuroradiol. 1996 May;17(5):965-72
8733975
Am J Geriatr Psychiatry. 2006 Oct;14(10):834-41
17001023
J Endocrinol Invest. 1994 Apr;17(4):241-5
7930374